CanChip GmbH won first place in the SDG 3 category of the renowned EUTECH SDG Awards 2024, which recognize initiatives making a significant contribution to achieving the United Nations Sustainable Development Goals (SDGs). This award honors CanChip’s innovative approach to improving global health and wellbeing through its pioneering Cancer-on-Chip research. These technologies enable groundbreaking solutions for effective drug testing and cancer therapies.
The SDG Awards, hosted by the SDG Alliance of the European Chamber of Technology, honor projects that demonstrate strong commitment to sustainable development and social impact. Winning this award underscores CanChip’s commitment to better health outcomes and to advancing technological progress that benefits society worldwide.